PLx Pharma Files For IPO

Houston-based PLx Pharma, a biopharmaceuticals developer which is developing compounds to improve oral absorption of drugs, has filed for an IPO, saying that it is looking to raise up to $20M in an offering on the NASDAQ Capital Market. The company says it is looking to trade as PLXP. The company has a single underwriter on its offering, Maxim Group LLC. PLx Pharma is venture backed by Aurus Bbios Fondo de Inversion, Integra Ventures, and others.